http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0061143-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_faa200a98720f74983d33279f21fc1c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f76f00972031256c5c9a5f583dfc3797
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b60893d3fdd32174371e59df90105e77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed1bc3695ba6d9b2ea95f36a9e24ca1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_32cc7576aade2d7dea747cb203e60628
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-385
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04
filingDate 2000-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e24333632f6f6c8035b1e54d926c232
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b58f32422cc36df98e56ad2a15ba2f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9626fea7d0eda97ee475aadf27977226
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdddeab1574ec7700ff0ae751ee216b9
publicationDate 2000-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0061143-A1
titleOfInvention The use of alpha lipoic acid in the antimetastatic treatment
abstract The invention relates to the use of alpha lipoic acid, also known as lipoic acid, thioctic acid or 1,2-dithiolan-3-pentanoic acid,as well as derivatives thereof, in the control of tumour progression and in the antimetastatic therapy.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2959668-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2260019-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2268278-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011138565-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2268278-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011516473-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011513395-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2260019-A1
priorityDate 1999-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9836773-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CH-683920-A5
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9906040-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0024734-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5679697-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9513061-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119031
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362422
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31423
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID864
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127401708
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127490147
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399223
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57248070
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127401709
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226434370
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128886153
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400163
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7839
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6112
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128950209
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1674
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396351
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226784547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135741642
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73950188

Total number of triples: 57.